Oncologix Tech (OCLG) Short Interest Ratio & Short Volume

Short interest is the volume of Oncologix Tech shares that have been sold short but have not yet been closed out or covered. As of December 15th, investors have sold 115,900 shares of OCLG short. Learn More on Oncologix Tech's current short interest.

Oncologix Tech saw a increase in short interest in December. As of December 15th, there was short interest totaling 115,900 shares, an increase of 49.2% from the previous total of 77,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "surgical & medical instruments" compare to Oncologix Tech: Nyxoah S.A. (0.53%), Stevanato Group S.p.A. (6.22%), Stryker Co. (1.17%), Boston Scientific Co. (0.91%), Becton, Dickinson and Company (0.77%), 3M (1.69%), DexCom, Inc. (2.20%), ResMed Inc. (6.72%), West Pharmaceutical Services, Inc. (1.77%), Fresenius SE & Co. KGaA (0.00%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Canadian Natural Resources Limited ($4.67 billion), General Motors ($4.33 billion), T-Mobile US, Inc. ($4.30 billion), Charter Communications, Inc. ($3.12 billion), Coinbase Global, Inc. ($3.12 billion), Occidental Petroleum Co. ($2.94 billion), Tractor Supply ($2.71 billion), Rivian Automotive, Inc. ($2.32 billion), United Rentals, Inc. ($2.22 billion), and Royal Caribbean Cruises Ltd. ($2.04 billion). View all of the most shorted stocks.

Short selling OCLG is an investing strategy that aims to generate trading profit from Oncologix Tech as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Oncologix Tech occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of OCLG, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OCLG, twice per month. The most recent reporting period available is December, 15 2023.